Cosmos Health Gets 180-Day Nasdaq Extension to Avoid Delisting
COSM is trading near its 52-week low of $0.195 (9.3% above the low) on light trading volume (0.3× avg).
Summary
Cosmos Health has secured an additional 180-day extension from Nasdaq, pushing its deadline to regain compliance with the $1.00 minimum bid price requirement to December 7, 2026. This reprieve temporarily removes the immediate threat of delisting for the company. This news follows recent 10-K and 10-Q filings that reported going concern warnings, widened losses, increased cash burn, and substantial share dilution. Management stated that a reverse stock split is a measure of last resort. The company must achieve a closing bid price of at least $1.00 for ten consecutive business days by the new deadline.
At the time of this announcement, COSM was trading at $0.21 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $12.8M. The 52-week trading range was $0.20 to $1.32. This news item was assessed with neutral market sentiment and an importance score of 7 out of 10. Source: GlobeNewswire.